表没食子儿茶素没食子酸酯减轻小鼠II度角膜碱烧伤损伤
该研究先以兔角膜上皮细胞系RCE1(5T5)确定EGCG的最佳测试条件,再在小鼠II度角膜碱烧伤模型中每日滴眼3次至21天。10μM EGCG可促进细胞分化而不引起凋亡或细胞毒性,并显著减轻角膜混浊、新生血管、水肿和炎症,改善上皮形态。
要点
- 10μM EGCG可促进角膜上皮细胞分化,不引起凋亡或细胞毒性。
- 小鼠II度角膜碱烧伤每日滴眼3次至21天,EGCG显著减轻角膜混浊和新生血管。
- EGCG减轻角膜、基质和内皮水肿及伤口炎症,上皮形态接近正常。
核心结论
- EGCG可用于角膜碱烧伤急性期,作为辅助治疗改善患者结局的潜在新选择。
研究设计与样本
- 实验研究:先在兔角膜上皮细胞系RCE1(5T5)上确定EGCG最佳测试条件,再在小鼠II度角膜碱烧伤模型中每日滴眼3次至21天。
主要发现
- EGCG以浓度依赖方式减少细胞生长并降低增殖细胞比例。
- 10μM EGCG促进细胞分化,该效应与凋亡或细胞毒性无关。
- 10μM EGCG每日3次至21天显著减轻小鼠角膜混浊和新生血管。
- EGCG减轻角膜、基质和内皮水肿及伤口炎症,上皮形态接近正常。
关键数值与推荐
- 细胞实验使用10μM EGCG促进分化。
- 动物实验使用10μM EGCG每日滴眼3次,持续至21天。
临床怎么用
- EGCG可作为角膜碱烧伤急性期的辅助治疗选项,需进一步临床验证。
局限性
- 研究为动物实验,样本量和具体统计值未在摘要中报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns. MATERIALS AND METHODS: Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization. RESULTS: EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation. CONCLUSION: This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy.
引用
- Gulias-Cañizo R, Lagunes-Guillén A, González-Robles A, et al. (-)-Epigallocatechin-3-gallate, reduces corneal damage secondary from experimental grade II alkali burns in mice. Burns. 2018. PMID: 30600126. doi:10.1016/j.burns.2018.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。